129 related articles for article (PubMed ID: 25130796)
1. Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation.
Poujol-Robert A; Boëlle PY; Conti F; Durand F; Duvoux C; Wendum D; Paradis V; Mackiewicz V; Chazouillères O; Corpechot C; Poupon R
Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):570-6. PubMed ID: 25130796
[TBL] [Abstract][Full Text] [Related]
2. A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.
do O NT; Eurich D; Schmitz P; Schmeding M; Heidenhain C; Bahra M; Trautwein C; Neuhaus P; Neumann UP; Wasmuth HE
Liver Transpl; 2012 Mar; 18(3):298-304. PubMed ID: 22139994
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
[TBL] [Abstract][Full Text] [Related]
4. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
[TBL] [Abstract][Full Text] [Related]
5. Peritransplant absolute lymphocyte count as a predictive factor for advanced recurrence of hepatitis C after liver transplantation.
Nagai S; Yoshida A; Kohno K; Altshuler D; Nakamura M; Brown KA; Abouljoud MS; Moonka D
Hepatology; 2014 Jan; 59(1):35-45. PubMed ID: 23728831
[TBL] [Abstract][Full Text] [Related]
6. Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence.
Ghabril M; Dickson RC; Krishna M; Machicao V; Aranda-Michel J; Bonatti H; Nguyen JH
Liver Transpl; 2011 Jun; 17(6):685-94. PubMed ID: 21618689
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis C after liver transplantation.
Guillaud O; Gurram KC; Puglia M; Lilly L; Adeyi O; Renner EL; Selzner N
Transplant Proc; 2013; 45(6):2331-6. PubMed ID: 23953545
[TBL] [Abstract][Full Text] [Related]
8. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
Neumann UP; Berg T; Bahra M; Seehofer D; Langrehr JM; Neuhaus R; Radke C; Neuhaus P
J Hepatol; 2004 Nov; 41(5):830-6. PubMed ID: 15519657
[TBL] [Abstract][Full Text] [Related]
9. Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation.
Carrión JA; Torres F; Crespo G; Miquel R; García-Valdecasas JC; Navasa M; Forns X
Hepatology; 2010 Jan; 51(1):23-34. PubMed ID: 19839063
[TBL] [Abstract][Full Text] [Related]
10. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
11. Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: a French experience on 250 patients over 15 years (the Orfèvre study).
Dumortier J; Salamé E; Roche B; Hurtova M; Conti F; Radenne S; Vanlemmens C; Pageaux GP; Saliba F; Samuel D; Compagnon P; Neau-Cransac M; Calmus Y; Guillaud O; Gugenheim J; Altieri M; Durand F; Hardwigsen J; Lorho R; Dharancy S; Leroy V; Di Giambattista F; Duvoux C
Clin Res Hepatol Gastroenterol; 2014 Jun; 38(3):292-9. PubMed ID: 24685602
[TBL] [Abstract][Full Text] [Related]
12. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
Berres ML; Trautwein C; Schmeding M; Eurich D; Tacke F; Bahra M; Neuhaus P; Neumann UP; Wasmuth HE
Hepatology; 2011 Feb; 53(2):596-603. PubMed ID: 21274880
[TBL] [Abstract][Full Text] [Related]
13. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C.
Wali M; Harrison RF; Gow PJ; Mutimer D
Gut; 2002 Aug; 51(2):248-52. PubMed ID: 12117889
[TBL] [Abstract][Full Text] [Related]
14. Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus-infected patients.
O'Leary JG; Kaneku H; Jennings L; Susskind BM; Terasaki PI; Klintmalm GB
Liver Transpl; 2014 Jun; 20(6):655-63. PubMed ID: 24678017
[TBL] [Abstract][Full Text] [Related]
15. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
16. Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C.
Howell J; Sawhney R; Angus P; Fink M; Jones R; Wang BZ; Visvanathan K; Crowley P; Gow P
Transpl Infect Dis; 2013 Dec; 15(6):588-99. PubMed ID: 24028328
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center.
Walter T; Dumortier J; Guillaud O; Hervieu V; Scoazec JY; Boillot O
Liver Transpl; 2007 Feb; 13(2):294-301. PubMed ID: 17256784
[TBL] [Abstract][Full Text] [Related]
18. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation.
Toniutto P; Fabris C; Bortolotti N; Minisini R; Avellini C; Fumo E; Pirisi M
J Hepatol; 2004 Aug; 41(2):307-11. PubMed ID: 15288481
[TBL] [Abstract][Full Text] [Related]
20. Early periportal sinusoidal fibrosis is an accurate marker of accelerated HCV recurrence after liver transplantation.
Mariño Z; Mensa L; Crespo G; Miquel R; Bruguera M; Pérez-Del-Pulgar S; Bosch J; Forns X; Navasa M
J Hepatol; 2014 Aug; 61(2):270-7. PubMed ID: 24703854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
